首页> 外文期刊>Journal of plastic, reconstructive & aesthetic surgery: JPRAS >Diagnostic value and safety of dynamic MRI of contralateral breast and axilla in subjects with tissue expander
【24h】

Diagnostic value and safety of dynamic MRI of contralateral breast and axilla in subjects with tissue expander

机译:组织扩展器对侧乳腺癌和腋窝动态MRI的诊断价值与安全

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

IntroductionTo verify the diagnostic value of contrast-enhanced breast and axillary MRI in patients with tissue expander labeled as “MR-unsafe” and to confirm its safety. Patients and methodsBreast MRI examinations performed in patients with tissue expander in the period from August 2010 to December 2017 were reviewed after IRB approval. In the case of breast lesion or lymph node, breast MRI exams after definitive prosthetic replacement were used for comparison. Breast MRI was performed using 1.5?T equipment with a dedicated coil. The protocol included axial STIR sequence and axial dynamic sequence with fat suppression (1 pre-contrast and 4 post-contrast phases). Two radiologists experienced in breast imaging reviewed images using six parameters for image quality evaluation.t-Test for dependent samples, Wilcoxon and Sign test were used. ResultsTwenty-three patients (49?±?9 years, range 34–68 years) with tissue expander who underwent contrast-enhanced MRI were reviewed. Thirteen breast lesions (12.92?±?4.84?mm) and eleven lymph nodes (11.00?±?4.29?mm) were found. In breast MRI examinations used for comparison no significant difference was observed in breast lesions (12.69?±?4.71?mm,P?=?0.707) or lymph node dimensions (10.58?±?3.00?mm,P?=?0.538). No significant difference was observed in lesion classification. A significantly lower visibility was observed for vascular maps (P?
机译:介绍验证对比增强乳腺癌和腋生MRI的诊断价值,患者标记为“MR-UNSAFE”并确认其安全性。 2010年8月至2017年10月期间,在2010年8月至2017年12月的组织扩展患者中进行了患者和培训率MRI检查。在乳腺病变或淋巴结的情况下,使用明确的假体更换后的乳房MRI考试进行比较。使用具有专用线圈的1.5·T设备进行乳房MRI。该方案包括轴向搅拌序列和具有脂肪抑制的轴向动态序列(1个预造影和4个后对比度相)。使用六个参数进行乳房成像的两位辐射学家,用于使用六个参数进行图像质量评估。用于依赖样品,使用WILCOXON和标志试验。综述了患有接受对比增强MRI的组织扩展器的组织扩展器(49?±9年,范围34-68岁)。发现十三乳房病变(12.92?±4.84毫米)和11个淋巴结(11.00?±4.29毫米)。在乳房MRI检查中,用于比较的检查在乳腺病变中没有观察到显着差异(12.69?±4.71?mm,p?=?0.707)或淋巴结尺寸(10.58?±3.00?mm,p?= 0.538)。在病变分类中没有观察到显着差异。观察到血管图的显着降低的可见度(p?<〜0.001)。没有一个患者报告了加热或皮肤灼伤的感觉。没有一个患者在MRI检查后揭示了任何临床效应或病理迹象。结论当必要时,在足够的信息和准备后,可以在组织扩展器患者中进行对比增强的乳房MRI,保持其诊断价值和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号